Recently diagnosed with HIV? Click here

Defeating HIV

NAPWHA is a key partner in Australia's coordinated response to HIV. Working with governments, the pharmaceutical industry, the research sector and other community-based organisations, NAPWHA ensures that the voices of people with HIV are heard at every level of the response.

NAPWHA is committed to action to reduce HIV infections in Australia and our region, and to improve the capacity of communities affected by HIV to participate in the response to the epidemic.

Report from Rome - 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention

Story • www.i-base.info • 28 July 2011

The 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention was held in Rome last week from 17-20 July. This meeting is held every two years and alternates with the much larger World AIDS Conferences also organised by the International AIDS Society (IAS). read more »

HIV. No big deal?

Positive Living article • David Menadue • 26 July 2011

‘So, what’s the big deal about having HIV?’ This is what a friend asked David Menadue, recently.

‘You look okay. It’s a manageable condition, now,’ he said. ‘Sometimes I think you guys make too much fuss about it all.’ read more »

Scare tactics

Positive Living article • David Menadue • 25 June 2011

David Menadue questions the use of fear in HIV prevention campaigns.

‘Bring back the Grim Reaper!’ they say. ‘You need a fear-based campaign to shock people into the awful reality of HIV.’

We’re familiar with this type of sentiment. It usually appears in the letters column of the gay press following any announcement that HIV numbers are up in the community. read more »

UN sets ambitious goal on new infections

Positive Living article • Adrian Ogier • 27 May 2011
Defeating HIV

The united Nations has set an ambitious goal of no new HIV infections or AIDS related deaths by 2015.

The UN Secretary General’s 2011 Report on AIDS highlights new strategies in the fight against the disease and urges universal access to treatment, care, and support, and an end to discrimination. read more »

Farewell, Liz. And thank you!

Positive Living article • Adrian Ogier • 27 May 2011

I will not be silenced and I will not give up and I will not be ignored.

With these words, Elizabeth Taylor lent her voice to the voiceless, her iconic image to those who had previously been invisible, and her compassion and determination to a cause many others had shunned: the fight against HIV. read more »

New hope for vaccine

Positive Living article • Adrian Ogier • 26 May 2011

Melbourne university researchers have identified antibodies in a breakthrough that brings closer the hope of developing an effective vaccine.

A study of 100 people with HIV, recruitedThe act of signing up participants into a study. Generally this process involves evaluating a participant with respect to the eligibility criteria of the study and going through the informed consentThe process of learning the key facts about a clinical trial before deciding whether or not to participate. It is also a continuing process throughout the study to provide information for participants. To help someone decide whether or not to participate, the doctors and nurses involved in the trial explain the details of the study. process. from The Alfred Hospital and the Melbourne Sexual Health Centre, has shown that antibodies were so successful in suppressing the virusA small infective organism which is incapable of reproducing outside a host cell. that it had to mutate around them. read more »

Treatment reduces transmission risk

Positive Living article • Adrian Ogier • 26 May 2011
HIV prevention

We have known for some time that HAARTHighly Active AntiRetroviralA medication or other substance which is active against retroviruses such as HIV. Therapy ??? aggressive treatment of HIV infection using several different drugs together. reduces the likelihood of transmitting HIV, and the recent results from a large clinical trialA clinicalPertaining to or founded on observation and treatment of participants, as distinguished from theoretical or basic science. trial is a research study to answer specific questions about vaccines or new therapies or new ways of using known treatments. Clinical trials are used to determine whether new drugs or treatments are both safe and effective. Carefully conducted clinical trials are the fastest and safest way to find treatments that work in people. Trials are in four phases: Phase IA clinical trial designed to establish whether an experimental drug is safe for humans to take. Phase I studies determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and look for early evidence of effectiveness; these studies may include either people with HIV, HIV-negative volunteers, or both tests a new drug or treatment in a small group; Phase IIA smaller clinical trial designed to establish whether a drug is effective. Phase II studies are conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks. If there is evidence that the drug is effective, a Phase III study is undertaken, with a larger number of participaants, to confirm this. expands the study to a larger group of people; Phase IIIA large clinical trial designed to establish whether a drug is effective and safe enough for widespread use. Phase III studies include expanded controlled and uncontrolled trials after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug and provide and adequate basis for physician labeling. expands the study to an even larger group of people; and Phase IVPost-marketing studies to delineate additional information including the drug's risks, benefits, and optimal use. takes place after the drug or treatment has been licensed and marketed. seem to confirm the fact . . . in heterosexual couples, at least. read more »

HIV treatments as prevention findings welcomed by people living with HIV

Media release • 13 May 2011

Today’s announcement that a clinical trialA clinicalPertaining to or founded on observation and treatment of participants, as distinguished from theoretical or basic science. trial is a research study to answer specific questions about vaccines or new therapies or new ways of using known treatments. Clinical trials are used to determine whether new drugs or treatments are both safe and effective. Carefully conducted clinical trials are the fastest and safest way to find treatments that work in people. Trials are in four phases: Phase IA clinical trial designed to establish whether an experimental drug is safe for humans to take. Phase I studies determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and look for early evidence of effectiveness; these studies may include either people with HIV, HIV-negative volunteers, or both tests a new drug or treatment in a small group; Phase IIA smaller clinical trial designed to establish whether a drug is effective. Phase II studies are conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks. If there is evidence that the drug is effective, a Phase III study is undertaken, with a larger number of participaants, to confirm this. expands the study to a larger group of people; Phase IIIA large clinical trial designed to establish whether a drug is effective and safe enough for widespread use. Phase III studies include expanded controlled and uncontrolled trials after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug and provide and adequate basis for physician labeling. expands the study to an even larger group of people; and Phase IVPost-marketing studies to delineate additional information including the drug's risks, benefits, and optimal use. takes place after the drug or treatment has been licensed and marketed. has found that HIV antiretroviralA medication or other substance which is active against retroviruses such as HIV. treatment significantly reduces the risk of HIV transmission is welcome news, the National Association of People Living with HIV/AIDS (NAPWHA) has said. read more »

Reviewing the global response

Positive Living article • Adrian Ogier • 3 March 2011
The global HIV epidemic

Late last year, The United Nations General Assembly called for a High Level Meeting to take place in June this year to review of the progress achieved so far and to promote the continued engagement of leaders in a comprehensive global response to HIV. read more »

What's Your Problem?

Positive Living article • Dr Louise Owen • 25 February 2011

Doctor Louise answers readers' questions. In this issue she discusses Hepatitis C infection and unprotected sex. read more »

Syndicate content
Text size: font smallerfont normalfont larger

Stay in touch

NAPWHA's email newsletters provide regular info about issues affecting people with HIV and the response to HIV in Australia. Click here to subscribe.

Subscribe to Positive Living

Our free quarterly newsmagazine, Positive Living provides authoritative, independent information about living with HIV and HIV treatments. Click here to subscribe.

RSS feeds

Our website has RSS feeds covering all topic areas — just go to the topic area you're interested in and click the RSS feed icon.

Twitter users can stay up-to-date with NAPWHA's work and be alerted to new content on the website by following @napwa.

Join us on Facebook NAPWHA Facebook.

Find out more at LinkedIn

Find out more about NAPWHA at LinkedInNAPWHA at LinkedIn.